logo

Health News

Share
ecigeratte-oct18.jpgAt a time, when e-cigarettes have been getting a lot of bad press, a new study has found a positive association between the number of people using e-cigarettes and the success rate of giving up smoking. The study led by Dr. Emma Beard, UCL Division of Psychology and Language Sciences, showed that...
Read More

Australia-based medicinal cannabis company Creso Pharma has intensified its focus on animal health, saying it plans to launch two additional hemp-derived products this year to improve the well-being of pets. Creso Pharma hopes to continue leveraging the rising global trend of the 'humanisation' of...
Read More
elmiron-oct14.jpg

Interstitial Cystitis Drug Linked To Retinal Damage: Study



Elmiron, the only FDA-approved oral drug to treat interstitial cystitis, also known as bladder pain syndrome, has been found to be associated with a vision-threatening eye condition, according to a new study.
Read More
pigs-april18.jpg

No Piggy Tale: Some Brain Functions Restored Even Hours After Death



The conventional wisdom is that if the brain cells of humans and other mammals are deprived of oxygen for 4-5 min, they begin to die, and that the loss of brain functions after death is irreversible. But the findings of a study conducted by Yale University researchers challenge these long-held assumptions.
Read More
bornbaby-sept30.jpgA recent study, done by researchers from the Wellcome Sanger Institute, UCL, the University of Birmingham and their collaborators, found that there is a difference in the gut bacteria of babies delivered vaginally and those born via caesarean.
Read More
Follow RTT


FDA Calendar
Event DateSymbolDrug NameEvent Name
04/26/20NBIXOpicapone (NDA)FDA decision on Opicapone as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes.
04/25/20SNYNF, SNYMenQuadfi (BLA)FDA decision on MenQuadfi to prevent meningococcal meningitis
04/17/20AZN.L, AZNTrastuzumab deruxtecan (BLA)FDA decision on Trastuzumab deruxtecan or treatment of patients with HER2-positive metastatic breast cancer
04/04/20LLYEmpagliflozin/Iinagliptin/Metformin Triple Combination Tablet (NDA)FDA decision on the triple combination tablet for adults with Type 2 Diabetes
04/04/20BMYLuspatercept (BLA)FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia
04/04/20XLRNLuspatercept (BLA)FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia
View All




>